Paul W. Hoelscher Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Paul W. Hoelscher is EVP, CFO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 1,049 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Apr 20, 2022, when has been sold 50,000 shares (Ordinary Shares) at a price of $114.76 per share, resulting in proceeds of $5,738,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.05K

0% 3M change

0% 12M change

Total Value Held $0

Paul W. Hoelscher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 20 2022	SELL Open market or private sale	$5,738,000 $114.76 p/Share	50,000 Reduced 97.95%	1,049 Ordinary Shares
Apr 20 2022	BUY Exercise of conversion of derivative security	$1,107,000 $22.14 p/Share	50,000 Added 49.48%	51,049 Ordinary Shares
Apr 06 2022	SELL Open market or private sale	$23,689,004 $110.01 p/Share	215,335 Reduced 99.52%	1,049 Ordinary Shares
Apr 06 2022	BUY Exercise of conversion of derivative security	$4,102,132 $19.05 p/Share	215,335 Added 49.88%	216,384 Ordinary Shares
Mar 23 2022	SELL Open market or private sale	$2,869,900 $110.0 p/Share	26,090 Reduced 96.13%	1,049 Ordinary Shares
Mar 23 2022	BUY Exercise of conversion of derivative security	$416,396 $15.96 p/Share	26,090 Added 49.01%	27,139 Ordinary Shares
Mar 07 2022	SELL Bona fide gift	-	66,626 Reduced 98.45%	1,049 Ordinary Shares

Jan 21 2022	SELL Payment of exercise price or tax liability	$212,852 $86.42 p/Share	2,463 Reduced 3.51%	67,675 Ordinary Shares
Jan 21 2022	BUY Exercise of conversion of derivative security	-	5,558 Added 7.34%	70,138 Ordinary Shares
Jan 05 2022	SELL Payment of exercise price or tax liability	$5,159,825 $101.84 p/Share	50,666 Reduced 43.96%	64,580 Ordinary Shares
Jan 05 2022	BUY Exercise of conversion of derivative security	-	66,822 Added 49.61%	67,871 Ordinary Shares
Jan 05 2022	BUY Grant, award, or other acquisition	-	47,375 Added 29.13%	115,246 Ordinary Shares
Dec 28 2021	SELL Open market or private sale	$943,250 $110.0 p/Share	8,575 Reduced 89.1%	1,049 Ordinary Shares
Dec 28 2021	BUY Exercise of conversion of derivative security	$136,857 $15.96 p/Share	8,575 Added 47.12%	9,624 Ordinary Shares
Dec 03 2021	SELL Bona fide gift	-	1,049 Reduced 50.0%	1,049 Ordinary Shares
Aug 25 2021	SELL Bona fide gift	-	6,163 Reduced 74.6%	2,098 Ordinary Shares
Jul 28 2021	SELL Payment of exercise price or tax liability	$395,445 $102.5 p/Share	3,858 Reduced 31.83%	8,261 Ordinary Shares
Jul 28 2021	BUY Grant, award, or other acquisition	-	8,708 Added 41.81%	12,119 Ordinary Shares
Feb 17 2021	SELL Payment of exercise price or tax liability	$91,093 $87.17 p/Share	1,045 Reduced 30.67%	2,362 Ordinary Shares
Feb 17 2021	BUY Grant, award, or other acquisition	-	2,358 Added 40.9%	3,407 Ordinary Shares
Feb 01 2021	SELL Bona fide gift	-	3,094 Reduced 74.68%	1,049 Ordinary Shares
Jan 21 2021	SELL Payment of exercise price or tax liability	$190,633 $77.43 p/Share	2,462 Reduced 37.27%	4,143 Ordinary Shares
Jan 21 2021	BUY Exercise of conversion of derivative security	-	5,556 Added 45.69%	6,605 Ordinary Shares
Jan 19 2021	SELL Bona fide gift	-	169,132 Reduced 99.38%	1,049 Ordinary Shares
Jan 05 2021	SELL Payment of exercise price or tax liability	$9,870,669 $73.28 p/Share	134,698 Reduced 44.18%	170,181 Ordinary Shares

Also insider at

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

Director

SGMT

Sagimet Biosciences Inc.

Director

PWH

Paul W. Hoelscher

EVP, CFO

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Value

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP

Account